174 related articles for article (PubMed ID: 36904210)
1. Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort.
Li L; Lutsey PL; Chen LY; Soliman EZ; Rooney MR; Alonso A
Nutrients; 2023 Feb; 15(5):. PubMed ID: 36904210
[No Abstract] [Full Text] [Related]
2. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.
Raparelli V; Pastori D; Pignataro SF; Vestri AR; Pignatelli P; Cangemi R; Proietti M; Davì G; Hiatt WR; Lip GYH; Corazza GR; Perticone F; Violi F; Basili S;
Intern Emerg Med; 2018 Aug; 13(5):651-660. PubMed ID: 29582316
[TBL] [Abstract][Full Text] [Related]
3. Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.
Magnani JW; Norby FL; Agarwal SK; Soliman EZ; Chen LY; Loehr LR; Alonso A
JAMA Cardiol; 2016 Jul; 1(4):433-41. PubMed ID: 27438320
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
[TBL] [Abstract][Full Text] [Related]
5. Serum magnesium and the incidence of coronary artery disease over a median 27 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study and a meta-analysis.
Rooney MR; Alonso A; Folsom AR; Michos ED; Rebholz CM; Misialek JR; Chen LY; Dudley S; Lutsey PL
Am J Clin Nutr; 2020 Jan; 111(1):52-60. PubMed ID: 31622458
[TBL] [Abstract][Full Text] [Related]
6. Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals.
Dalila N; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
Atherosclerosis; 2023 Jul; 376():26-33. PubMed ID: 37263031
[TBL] [Abstract][Full Text] [Related]
7. Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
Pastori D; Pignatelli P; Saliola M; Carnevale R; Vicario T; Del Ben M; Cangemi R; Barillà F; Lip GY; Violi F
Int J Cardiol; 2015 Dec; 201():513-6. PubMed ID: 26318513
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study.
Menichelli D; Sciacqua A; Cangemi R; Andreozzi P; Del Sole F; Violi F; Pignatelli P; Pastori D;
Int J Clin Pract; 2021 Mar; 75(3):e13771. PubMed ID: 33078565
[TBL] [Abstract][Full Text] [Related]
9. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
[TBL] [Abstract][Full Text] [Related]
10. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
[TBL] [Abstract][Full Text] [Related]
11. Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
Polovina M; Hindricks G; Maggioni A; Piepoli M; Vardas P; Ašanin M; Ðikic D; Ðuricic N; Milinkovic I; Seferovic PM
Eur Heart J; 2018 Dec; 39(45):4030-4039. PubMed ID: 30101326
[TBL] [Abstract][Full Text] [Related]
12. Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years.
Seki H; Kaneko H; Morita H; Itoh H; Morita K; Matsuoka S; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Yano Y; Nakamura S; Node K; Yasunaga H; Komuro I
Am J Cardiol; 2021 Aug; 152():150-157. PubMed ID: 34140140
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.
Hu WS; Lin CL
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1977-1986. PubMed ID: 36881169
[TBL] [Abstract][Full Text] [Related]
14. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.
Aronis KN; Zhao D; Hoogeveen RC; Alonso A; Ballantyne CM; Guallar E; Jones SR; Martin SS; Nazarian S; Steffen BT; Virani SS; Michos ED
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246963
[TBL] [Abstract][Full Text] [Related]
15. Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans--Atherosclerosis Risk in Communities (ARIC) study.
Misialek JR; Lopez FL; Lutsey PL; Huxley RR; Peacock JM; Chen LY; Soliman EZ; Agarwal SK; Alonso A
Circ J; 2013; 77(2):323-9. PubMed ID: 23047297
[TBL] [Abstract][Full Text] [Related]
16. Social determinants of health and cardiovascular outcomes in patients with heart failure.
Vinter N; Fawzy AM; Gent D; Ding WY; Johnsen SP; Frost L; Trinquart L; Lip GYH
Eur J Clin Invest; 2022 Nov; 52(11):e13843. PubMed ID: 35924957
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study.
Zwartkruis VW; Geelhoed B; Suthahar N; Bakker SJL; Gansevoort RT; van Gelder IC; de Boer RA; Rienstra M
Open Heart; 2021 Dec; 8(2):. PubMed ID: 34969833
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry.
Vitolo M; Malavasi VL; Proietti M; Diemberger I; Fauchier L; Marin F; Nabauer M; Potpara TS; Dan GA; Kalarus Z; Tavazzi L; Maggioni AP; Lane DA; Lip GYH; Boriani G;
Eur J Intern Med; 2022 May; 99():45-56. PubMed ID: 35177307
[TBL] [Abstract][Full Text] [Related]
19. New-Onset Atrial Fibrillation in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Registry.
Rosenblatt AG; Ayers CR; Rao A; Howell SJ; Hendren NS; Zadikany RH; Ebinger JE; Daniels JD; Link MS; de Lemos JA; Das SR
Circ Arrhythm Electrophysiol; 2022 May; 15(5):e010666. PubMed ID: 35475654
[TBL] [Abstract][Full Text] [Related]
20. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
Pandey A; Kim S; Moore C; Thomas L; Gersh B; Allen LA; Kowey PR; Mahaffey KW; Hylek E; Peterson ED; Piccini JP; Fonarow GC;
JACC Heart Fail; 2017 Jan; 5(1):44-52. PubMed ID: 28034376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
